Harindra Wijeysundera, MD, PhD
•	Harindra Wijeysundera, MD, PhD, Vice-President, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
Vice-President
Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Dr. Wijeysundera is the Vice-President, Medical Devices and Clinical Intervention at CADTH (Canadian Agency for Drugs and Technology in Health).  He continues an active academic clinical practice as an interventional cardiologist and clinician scientist at the Schulich Heart Center in Sunnybrook Health Sciences Center.  He is the director of research for the division of cardiology, and a scientist at Sunnybrook Research Institute as well as an adjunct senior scientist at the Institute for Clinical Evaluative Sciences (ICES).  He is an associate professor in the Department of Medicine and the Institute for Health Policy, Management and Evaluation (IHPME) at the University of Toronto. His clinical practice is focused on transcatheter aortic valve implantation (TAVI) and coronary chronic total occlusions.  His research program focuses on health technology assessments predominantly in cardiovascular disease using decision analytic models, which are populated and validated using real-world administrative data for both clinical outcomes and health care costs.